Skip to content
GenoLensGenoLens

IMPDH1

Chr 7q32.1

inosine monophosphate dehydrogenase 1

Aliases:
sWSS2608, LCA11
MANE:
ENST00000338791.11

Annotations refreshed 1 month ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Retinal disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Glaucoma (developmental)

  • Ophthalmological ciliopathies

  • Primary ciliary disorders

  • Rare multisystem ciliopathy disorders

  • Skeletal dysplasia

  • Structural eye disease

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Thoracic dystrophies

Disease associations (Open Targets)

  • retinitis pigmentosa

    0.73
  • retinitis pigmentosa 10

    0.68
  • Leber congenital amaurosis

    0.63
  • chronic hepatitis C virus infection

    0.60
  • hepatitis C virus infection

    0.60
  • Leber congenital amaurosis 11

    0.60
  • cirrhosis of liver

    0.59
  • acute lymphoblastic leukemia

    0.53
  • viral infectious disease

    0.46
  • Crohn disease

    0.45

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Inosine-5'-monophosphate dehydrogenase 1

Catalyzes the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP), the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, and therefore plays an important role in the regulation of cell growth. Could also have a single-stranded nucleic acid-binding activity and could play a role in RNA and/or DNA metabolism. It may also have a role in the development of malignancy and the growth progression of some tumors

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.